Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: The role of a sequencing-based clinical intestinal screening test in patients at high-risk for Clostridium difficile and other pathogens: a case report

Fig. 1

Selected results from the first SmartGut™ test report taken by the patient in November 2017 (Clostridium difficile negative). Three relevant parts of the clinical intestinal test SmartGut™ report generated after sample analysis are shown here: pathogens section, diarrhea from the infections section, and irritable bowel syndrome from the gut conditions section. The actual report is much more comprehensive and includes: other gut conditions such as inflammatory bowel disease, including ulcerative colitis and Crohn’s disease, and gastrointestinal symptoms; diet and lifestyle conditions, such as obesity, kidney stones, type 2 diabetes, non-alcoholic fatty liver disease, and prediabetes; and cardiovascular health conditions, such as atherosclerosis and cardiovascular disease, among others

Back to article page